About Us

Our Team

A specialized advisory firm dedicated to evolving life science companies & enhancing financial outcomes​

Our core mission is to guide organizations toward success by providing expert support that bridges the gap between financial and commercial domains, thereby unlocking the untapped value in the space between.

Patrick Coyle
Patrick Coyle

Patrick R. Coyle

Financial Strategy

Founder & CEO

Logos Novartis insmed eisai bayer deloitte

Patrick R Coyle is a Seasoned Pharma Executive with Expertise in the Economics of Healthcare

Patrick is the CEO and Founder of Novus Proximus. He helps businesses evolve and improve their financial outcomes through comprehensive analysis of financial structures and corporate strategy. Patrick has held various roles of increasing responsibility in strategic planning, information technology, market access, and corporate investment at global companies.

Most recently, he served as the Vice President and CFO of Eisai Inc. where he was responsible for leading financial operations across the Americas.

Patrick provides Industry Thought Leadership in Gross-to-Net (GTN) and drives insight generation that established best practices at top life sciences organizations. He is a Growth Driver that developed business improvement strategies that facilitated growth and achieved >$1B in net sales while out-performing margin targets for 3 products in Oncology & Immunology.

Patrick R. Coyle

Financial Strategy

Founder & CEO

About Patrick

Patrick Coyle

Patrick R. Coyle

Financial Strategy

Founder & CEO

Logos Novartis insmed eisai bayer deloitte

Patrick R Coyle is a Seasoned Pharma Executive with Expertise in the Economics of Healthcare

Patrick is the CEO and Founder of Novus Proximus. He helps businesses evolve and improve their financial outcomes through comprehensive analysis of financial structures and corporate strategy. Patrick has held various roles of increasing responsibility in strategic planning, information technology, market access, and corporate investment at global companies.

Most recently, he served as the Vice President and CFO of Eisai Inc. where he was responsible for leading financial operations across the Americas.

Patrick provides Industry Thought Leadership in Gross-to-Net (GTN) and drives insight generation that established best practices at top life sciences organizations. He is a Growth Driver that developed business improvement strategies that facilitated growth and achieved >$1B in net sales while out-performing margin targets for 3 products in Oncology & Immunology.

Nora Tsivgas
Nora Tsivgas

Nora Tsivgas

Access Strategy

Logos Smart Health Partners, Olgivy Common Health Worldwide, inVentiv Health, Pfizer

Nora Tsivgas is a Seasoned Market Access Executive that drives New Product Launch & Portfolio Optimization

Nora Tsivgas is a New Product Commercialization optimization expert across specialty, oncology and primary care markets. Her expertise in HCP, institutional and payer marketing expertise enables her to integrate teams, perspectives, and strategic direction to realize each brand’s full potential.

She has led initiatives to build patient navigation platforms to gain access and coverage for uninsured and underinsured patients, leveraging Medicaid expansion and the new public exchanges. Nora has extensive knowledge around healthcare reform, value-based benefit design, payment reform and healthcare quality improvement.

Over her 20+ year, Nora led field-based collaborative initiatives with large medical and oncology group practices, comprehensive cancer centers, large hospital systems and professional health organizations focused on quality improvement and clinical treatment pathways. She led the initial alignment and integration of payer access messaging and targeting strategies across the managed markets, marketing and sales organizations at Pfizer.

Nora Tsivgas

Access Strategy

About Nora

Nora Tsivgas

Nora Tsivgas

Access Strategy

Logos Smart Health Partners, Olgivy Common Health Worldwide, inVentiv Health, Pfizer

Nora Tsivgas is a Seasoned Market Access Executive that drives New Product Launch & Portfolio Optimization

Nora Tsivgas is a New Product Commercialization optimization expert across specialty, oncology and primary care markets. Her expertise in HCP, institutional and payer marketing expertise enables her to integrate teams, perspectives, and strategic direction to realize each brand’s full potential.

She has led initiatives to build patient navigation platforms to gain access and coverage for uninsured and underinsured patients, leveraging Medicaid expansion and the new public exchanges. Nora has extensive knowledge around healthcare reform, value-based benefit design, payment reform and healthcare quality improvement.

Over her 20+ year, Nora led field-based collaborative initiatives with large medical and oncology group practices, comprehensive cancer centers, large hospital systems and professional health organizations focused on quality improvement and clinical treatment pathways. She led the initial alignment and integration of payer access messaging and targeting strategies across the managed markets, marketing and sales organizations at Pfizer.

Najur Runganadhan
Najur Runganadhan

Najur Runganadhan

Commercial Strategy

Logos: Novartis, Pfizer, Wyeth, Johnson & Johnson, IQVIA

Najur Runganadhan is a Commercial Consulting leader that designs complex launches across platforms

Najur Runganadhan is a Commercial Consulting Leader that is responsible for ensuring the definition, execution and delivery of go-to-market, product launch, digital marketing/transform, commercial operations & big data/technology projects.

He has led and successfully delivered highly complex, multi-disciplinary commercial, analytical/AI & digital/big-data solutions across a wide variety of therapeutic areas, including small-molecule, biologics/vaccines and oncologic platforms.

Over his 20+ year career, Najur has worked across the life sciences ecosystem.  His educational background is in Mechanical Engineering (University of Minnesota, Minneapolis, MN) and Statistics and Economics (University of St. Thomas, St. Paul, MN).

Najur Runganadhan

Commercial Strategy

About Najur

Najur Runganadhan

Najur Runganadhan

Commercial Strategy

Logos: Novartis, Pfizer, Wyeth, Johnson & Johnson, IQVIA

Najur Runganadhan is a Commercial Consulting leader that designs complex launches across platforms

Najur Runganadhan is a Commercial Consulting Leader that is responsible for ensuring the definition, execution and delivery of go-to-market, product launch, digital marketing/transform, commercial operations & big data/technology projects.

He has led and successfully delivered highly complex, multi-disciplinary commercial, analytical/AI & digital/big-data solutions across a wide variety of therapeutic areas, including small-molecule, biologics/vaccines and oncologic platforms.

Over his 20+ year career, Najur has worked across the life sciences ecosystem.  His educational background is in Mechanical Engineering (University of Minnesota, Minneapolis, MN) and Statistics and Economics (University of St. Thomas, St. Paul, MN).

Jeff Chaffin
Jeff Chaffin

Jeff Chaffin

Payer Strategy

GSK logo

Jeff Chaffin is an accomplished Market Access leader with deep experience developing payer strategy

Jeff Chaffin specializes in making the most difficult projects successful by leveraging his diverse expertise in business strategy, claims analysis, customer engagement, and contracting. He has created, negotiated, and executed a strong portfolio of successful innovative agreements.

He has operated in a variety of both strategic and operational roles across market access strategy, national account engagement, and contracting. He has developed and led three teams during his tenure at GSK each providing unique new capabilities (Population Analysis, Economic value communication to national accounts, and innovative payer contracting).

Jeff earned his MS in Economics at North Carolina State University and was a visiting scholar at the Duke University of Behavioral Economics.

Jeff Chaffin

Payer Strategy

About Jeff

Jeff Chaffin

Jeff Chaffin

Payer Strategy

GSK logo

Jeff Chaffin is an accomplished Market Access leader with deep experience developing payer strategy

Jeff Chaffin specializes in making the most difficult projects successful by leveraging his diverse expertise in business strategy, claims analysis, customer engagement, and contracting. He has created, negotiated, and executed a strong portfolio of successful innovative agreements.

He has operated in a variety of both strategic and operational roles across market access strategy, national account engagement, and contracting. He has developed and led three teams during his tenure at GSK each providing unique new capabilities (Population Analysis, Economic value communication to national accounts, and innovative payer contracting).

Jeff earned his MS in Economics at North Carolina State University and was a visiting scholar at the Duke University of Behavioral Economics.

Wilmer Shaw
Wilmer Shaw

Wilmer Shaw

Project Management Orchestrator

Lgos, Eisai, insmed, united healthcare optum

Wilmer Shaw is the Project Management Orchestrator of strategy and execution to deliver successful outcomes

Wilmer Shaw is the Project Management Orchestrator who is entrusted with overseeing a team of exceptionally skilled project managers and managing diverse project portfolios. He is regularly called upon to address critical situations and spearhead risk management efforts to deliver projects successfully.

He has extensive experience across a wide array of corporate verticals across private and public sectors alike. His Demonstrated expertise in deftly navigating the intricacies of Health Insurance Companies, Hospitals, Financial Institutions, Banking, Marketing, Avionics, and Pharma corporations.

Wilmer holds a BA/BS from the State University of New York.

Wilmer Shaw

Project Management Orchestrator

About Wilmer

Wilmer Shaw

Wilmer Shaw

Project Management Orchestrator

Lgos, Eisai, insmed, united healthcare optum

Wilmer Shaw is the Project Management Orchestrator of strategy and execution to deliver successful outcomes

Wilmer Shaw is the Project Management Orchestrator who is entrusted with overseeing a team of exceptionally skilled project managers and managing diverse project portfolios. He is regularly called upon to address critical situations and spearhead risk management efforts to deliver projects successfully.

He has extensive experience across a wide array of corporate verticals across private and public sectors alike. His Demonstrated expertise in deftly navigating the intricacies of Health Insurance Companies, Hospitals, Financial Institutions, Banking, Marketing, Avionics, and Pharma corporations.

Wilmer holds a BA/BS from the State University of New York.

Tommy James
Tommy James

Tommy James

Solution Architect

Logos: planful, KPMG, belk

Tommy James is a seasoned Solution Architect with a proven track record of helping the evolution of Finance

Tommy James has a 25-year track record of helping the office of finance to analyze, design, and implement optimal solutions. He has deep knowledge and the ability to orchestrate applied technology solutions to finance problems. He brings significant expertise in Design & Delivery of Enterprise Performance Management (EPM) solutions for management reporting, planning, and modeling.

His role in Project Management & Oversight of small direct teams often integrates with a larger, matrixed client team.  This involves significant, hands-on involvement in project deliverables in all phases.

Tommy has been a Solutions Architect with Planful for >11 years delivering the best planning outcomes to 100+ clients. He also provides system administration to various implementations, including  Hyperion Essbase for 5 years .

Tommy James

Solution Architect

About Tommy

Tommy James

Tommy James

Solution Architect

Logos: planful, KPMG, belk

Tommy James is a seasoned Solution Architect with a proven track record of helping the evolution of Finance

Tommy James has a 25-year track record of helping the office of finance to analyze, design, and implement optimal solutions. He has deep knowledge and the ability to orchestrate applied technology solutions to finance problems. He brings significant expertise in Design & Delivery of Enterprise Performance Management (EPM) solutions for management reporting, planning, and modeling.

His role in Project Management & Oversight of small direct teams often integrates with a larger, matrixed client team.  This involves significant, hands-on involvement in project deliverables in all phases.

Tommy has been a Solutions Architect with Planful for >11 years delivering the best planning outcomes to 100+ clients. He also provides system administration to various implementations, including  Hyperion Essbase for 5 years .

Andrew Nye
Andrew Nye

Andrew Nye

Financial Analyst

Andrew Nye is the Financial Architect that creates models that bridge the gap between academic and corporate finance.

Andrew Nye is an entrepreneurial finance savant engaged in investment and corporate analysis. He leverages financial acumen to provide strategic advice on capital management, while analyzing and optimizing financial performance. He manages financial risks by using his data science capabilities to forecast market trends, which is essential for the dynamic nature of pharmaceutical manufacturing. Andrew graduated from the University of South Carolina with a degree in finance and a concentration in business analytics. While at South Carolina, he was a member of the Finance Scholars Program, a select academic cohort that admits the top 30 finance majors yearly.

Andrew Nye

Financial Analyst

About Andrew

Andrew Nye

Andrew Nye

Financial Analyst

Andrew Nye is the Financial Architect that creates models that bridge the gap between academic and corporate finance.

Andrew Nye is an entrepreneurial finance savant engaged in investment and corporate analysis. He leverages financial acumen to provide strategic advice on capital management, while analyzing and optimizing financial performance. He manages financial risks by using his data science capabilities to forecast market trends, which is essential for the dynamic nature of pharmaceutical manufacturing. Andrew graduated from the University of South Carolina with a degree in finance and a concentration in business analytics. While at South Carolina, he was a member of the Finance Scholars Program, a select academic cohort that admits the top 30 finance majors yearly.

Diversification Across Top Global Companies

bayer logo<br />
Eisai logo
Computer Horizons Corp. logo
nyc logo
insmed logo
novartis logo
sunchemical logo
united healthcare | optum logo